Sutro Biopharma Funding & Investors
Sutro Biopharma, Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro Biopharma serves the pharmaceutical industries throughout the United States.
sutrobio.comTotal Amount Raised: $486,604,992
Sutro Biopharma Funding Rounds
Post Ipo Debt
$140,000,000
Post Ipo Debt Investors
Blackstone Life SciencesPost Ipo Equity
$144,900,000
Post Ipo Equity Investors
Frazier ManagementSeries E
$85,400,000
Series E Investors
Samsara BioCapitalSurveyor CapitalEventideAmgen VenturesNexthera CapitalSV Health InvestorsCelgeneLilly VenturesSkyline VenturesTekla Capital ManagementVida VenturesMerckAlta PartnersCitadelCenteneSeries D
$26,000,000
Series D Investors
Alta PartnersSV Health InvestorsSkyline VenturesEli LillyCelgeneAmgen VenturesSeries C
$16,500,000
Series C Investors
SV Health InvestorsSkyline VenturesAmgen VenturesLilly VenturesAlta PartnersSeries C
$36,500,000
Series C Investors
Skyline VenturesAmgen VenturesLilly VenturesSV Health InvestorsAlta PartnersSeries B
$15,000,000
Series B Investors
Alta PartnersSV Health InvestorsSeries B
$21,000,000
Series B Investors
SV Health InvestorsAlta PartnersSeries Unknown
$305,000
Series Unknown Investors
International Biotechnology TrustSV Health InvestorsSeries A
$1,000,000
Series A Investors
SV Health Investors
Funding info provided by Diffbot.